Abbott Laboratories Stock Today
| ABT Stock | USD 104.77 0.03 0.03% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Abbott Laboratories is selling for under 104.77 as of the 13th of May 2024; that is 0.03 percent up since the beginning of the trading day. The stock's last reported lowest price was 104.4. Abbott Laboratories has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on February 6, 2024, Representative Kathy Manning of US Congress acquired under $15k worth of Abbott Laboratories's common stock.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.74 B outstanding shares of which 14.48 M shares are presently shorted by investors with about 2.74 days to cover. More on Abbott Laboratories
Moving against Abbott Stock
| 0.67 | BSX | Boston Scientific Corp | PairCorr |
| 0.6 | NXL | Nexalin Technology | PairCorr |
| 0.59 | BBLGW | Bone Biologics Corp Upward Rally | PairCorr |
| 0.53 | PHG | Koninklijke Philips | PairCorr |
| 0.49 | ESTA | Establishment Labs | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 18th of July 2024
Abbott Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Abbott Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Robert Ford |
| Thematic Ideas | (View all Themes) |
| Old Names | [Absolute Software Corporation, Abbott Laboratories, Aqua Bio Technology ASA, Abundant Produce Limited, Abbott Laboratories] |
| Business Concentration | Pharmaceutical Products, Medical Devices, Healthcare, NYSE Composite, Obamacare Repeal, SRI Sustainable Growth, Compulsion, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 and employs 114,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 182.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abbott Laboratories runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.74 B outstanding shares of which 14.48 M shares are presently shorted by investors with about 2.74 days to cover.
Abbott Laboratories has about 9.88 B in cash with 7.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.68.
Check Abbott Laboratories Probability Of Bankruptcy
Ownership AllocationAbbott Laboratories retains a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that on February 6, 2024, Representative Kathy Manning of US Congress acquired under $15k worth of Abbott Laboratories's common stock.
Check Abbott Ownership Details
Abbott Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Abbott Laboratories jumping above the current price in 90 days from now is about 92.36%. The Abbott Laboratories probability density function shows the probability of Abbott Laboratories stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Abbott Laboratories has a beta of 0.7412. This suggests as returns on the market go up, Abbott Laboratories average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Abbott Laboratories will be expected to be much smaller as well. Additionally, abbott Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Abbott Laboratories to move above the current price in 90 days from now is about 92.36 (This Abbott Laboratories probability density function shows the probability of Abbott Stock to fall within a particular range of prices over 90 days) .
Abbott Laboratories Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Abbott Laboratories market risk premium is the additional return an investor will receive from holding Abbott Laboratories long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Abbott Laboratories. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Abbott Laboratories' alpha and beta are two of the key measurements used to evaluate Abbott Laboratories' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.14) |
Abbott Stock Against Markets
Picking the right benchmark for Abbott Laboratories stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Abbott Laboratories stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Abbott Laboratories is critical whether you are bullish or bearish towards Abbott Laboratories at a given time. Please also check how Abbott Laboratories' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Abbott Laboratories Corporate Directors
Abbott Laboratories corporate directors refer to members of an Abbott Laboratories board of directors. The board of directors generally takes responsibility for the Abbott Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Abbott Laboratories' board members must vote for the resolution. The Abbott Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Samuel Scott | Independent Director | Profile | |
| Nancy McKinstry | Independent Director | Profile | |
| Phebe Novakovic | Independent Director | Profile | |
| Roxanne Austin | Independent Director | Profile |
How to buy Abbott Stock?
Before investing in Abbott Laboratories, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Abbott Laboratories. To buy Abbott Laboratories stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Abbott Laboratories. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Abbott Laboratories stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Abbott Laboratories stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Abbott Laboratories stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Abbott Laboratories, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Already Invested in Abbott Laboratories?
The danger of trading Abbott Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbott Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbott Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbott Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.